# REXAHN PHARMACEUTICALS INC (REXN)

> Institutional ownership reported to the SEC as of Q3 2020, from Form 13F filings. Source: https://holderbook.com/stocks/REXN/

- Reporting holders: 6
- Reported value: $764.0K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [RENAISSANCE TECHNOLOGIES LLC](https://holderbook.com/funds/1037389-renaissance-technologies-llc/) | $485.0K | 233,302 | 0.0% | 6 |
| [VANGUARD GROUP INC](https://holderbook.com/funds/102909-vanguard-group-inc/) | $158.0K | 75,634 | 0.0% | 6 |
| [GEODE CAPITAL MANAGEMENT, LLC](https://holderbook.com/funds/1214717-geode-capital-management-llc/) | $55.0K | 26,579 | 0.0% | 6 |
| [WEDBUSH SECURITIES INC](https://holderbook.com/funds/1142495-wedbush-securities-inc/) | $48.0K | 23,301 | 0.0% | 2 |
| [BlackRock Inc.](https://holderbook.com/funds/1364742-blackrock-inc/) | $18.0K | 8,830 | 0.0% | 6 |
| [American Portfolios Advisors](https://holderbook.com/funds/1961150-american-portfolios-advisors/) | $17 | 8 | 0.0% | 6 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2020 | 6 | $764.0K |
| Q2 2020 | 7 | $898.0K |
| Q1 2020 | 8 | $523.0K |
| Q4 2019 | 7 | $520.0K |
| Q3 2019 | 7 | $422.0K |
| Q2 2019 | 12 | $1.0M |
| Q4 2018 | 1 | $7.0K |